Biotechnology

Cell Culture Diagnostics Moderna Cholesterol Management Synthetic Biology Deep Learning Lung Cancer Immunology Biochemical Engineering Pharmaceutical Industry

Eli Lilly to Acquire Verve Therapeutics as Gene-Editing Trial Begins

The $1.3 billion purchase marks a major step in Lilly’s expansion into PCSK9-targeting therapies with closing slated for Q3 2025.

Engineered Yeast Converts Urine Into Implant-Grade Hydroxyapatite

Stories older than 24h

FDA Approves Lab-Grown Salmon, First Cultivated Seafood Authorized in the US

Machine Learning–Powered LOCA-PRAM Enhances Point-of-Care Disease Detection

Nanoneedle Patch Paves Way for Painless, Real-Time Disease Diagnostics

New Platforms Generate Functional Vascular Networks for 3D Bioprinting

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

US Arrests Third Chinese Scientist Over Crop Pathogen Smuggling

Nanoparticle Vaccine Clears Tumors in Over Half of Preclinical Pancreatic Cancer Models

mRNA Nanoparticles Reverse HIV Latency in Resting T Cells

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Japan Launches Trials of Universal Artificial Blood

EPFL’s MEDUSA Technique Yields Aptamers With Up to 1,000-Fold Stronger Viral Binding

Lung-Targeted Nanoparticles Deliver Genetic Therapies to Treat Cancer and Cystic Fibrosis

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Bristol Myers Squibb and BioNTech partner on $11 billion bispecific antibody cancer drug

Cornell Team Unveils Zwitterionic Polymer to Enhance mRNA Vaccine Delivery

CAPGLO Device Promises Rapid, Low-Cost T Cell Harvesting for CAR T Therapy

Breakthrough Vascularized Stem Cell Islet Organoids Advance Diabetes Research